Mutz Christopher
SEC CIK 1846487 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANIP | ANI PHARMACEUTICALS INC | HEAD OF RARE DISEASE | 91.3K | — | $2.86M | 29 | 2022-02-15 | 2026-03-13 |
Most active insiders at ANIP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lalwani Nikhil | Pres, CEO, Dir | — | $5.05M |
| 2 | Walsh Patrick D | Dir | — | $2.32M |
| 3 | CAREY STEPHEN P. | SVP, CFO | — | $1.78M |
| 4 | Mutz Christopher | HEAD OF RARE DISEASE | — | $1.64M |
| 5 | Gassert Chad | SVP - CORP. DEV, STRATEGY | — | $1.31M |
| 6 | Davis Krista | SVP, Chief HR Off | — | $918.6K |
| 7 | Gutwerg Ori | SVP, GENERICS | — | $621.4K |
| 8 | Cook Meredith | SVP, GC, SEC | — | $453.9K |
| 9 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | — | $393.8K |
| 10 | HAUGHEY THOMAS | Dir | — | $161.8K |
Transactions 29
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-13 | 2026-03-13 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $71.64 | -3,162 | 91.3K | -3% | -$226.5K | |
| M | 2026-03-10 | 2026-03-06+ | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $74.19 | -5,723 | 94.5K | -6% | -$424.6K |
| 2026-03-10 | 2026-03-07 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $74.04 | -3,314 | 98.1K | -3% | -$245.4K | |
| 2026-03-04 | 2026-03-02 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $74.00 | -417 | 103.5K | -0.4% | -$30.9K | |
| 2026-03-02 | 2026-02-26 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | A - Grant | $77.15 | +21.3K | 106.1K | +25% | +$1.64M | |
| 2026-03-02 | 2026-02-28 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $73.90 | -2,221 | 103.9K | -2% | -$164.1K | |
| 2026-02-23 | 2026-02-20 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $78.02 | -5,323 | 84.8K | -6% | -$415.3K | |
| 2026-02-17 | 2026-02-12 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $76.55 | -7,032 | 92.6K | -7% | -$538.3K | |
| M | 2026-02-17 | 2026-02-12+ | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $76.98 | -5,576 | 90.2K | -6% | -$429.3K |
| 2026-02-13 | 2026-02-11 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $76.25 | -4,546 | 102.8K | -4% | -$346.6K | |
| 2025-05-15 | 2025-05-14 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $60.45 | -4,000 | 107.3K | -4% | -$241.8K | |
| 2025-03-14 | 2025-03-07 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $60.62 | -2,874 | 111.3K | -3% | -$174.2K | |
| 2025-03-04 | 2025-02-28 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $61.89 | -1,275 | 114.2K | -1% | -$78.9K | |
| M | 2025-02-18 | 2025-02-14+ | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $58.92 | -2,657 | 116.7K | -2% | -$156.6K |
| M | 2025-02-18 | 2025-02-12 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | A - Grant | $0.00 | +41.3K | 118.1K | +54% | $0 |
| 2024-11-18 | 2024-11-15 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $57.70 | -6,500 | 76.8K | -8% | -$375.1K | |
| 2024-05-22 | 2024-05-21 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $61.61 | -2,000 | 83.3K | -2% | -$123.2K | |
| 2024-03-07 | 2024-03-07 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $66.71 | -2,110 | 85.3K | -2% | -$140.8K | |
| 2024-03-06 | 2024-03-05 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $66.00 | -5,000 | 87.4K | -5% | -$330.0K | |
| 2024-03-01 | 2024-02-29 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $67.67 | -1,275 | 92.4K | -1% | -$86.3K | |
| 2024-02-20 | 2024-02-15 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $57.55 | -1,261 | 93.7K | -1% | -$72.6K | |
| M | 2024-02-16 | 2024-02-14 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | A - Grant | $0.00 | +31.3K | 94.9K | +49% | $0 |
| 2023-11-13 | 2023-11-10 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $52.47 | -3,000 | 63.6K | -5% | -$157.4K | |
| M | 2023-04-04 | 2023-02-28 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | A - Grant | $0.00 | +28.9K | 55.0K | +111% | $0 |
| M | 2023-03-09 | 2023-03-07 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $44.23 | -1,902 | 38.1K | -5% | -$84.1K |
| 2023-02-17 | 2023-02-15 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $45.04 | -1,292 | 39.6K | -3% | -$58.2K | |
| 2022-04-29 | 2022-04-27 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | A - Grant | $0.00 | +6,476 | 40.9K | +19% | $0 | |
| 2022-03-28 | 2022-03-24 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | A - Grant | $0.00 | +19.4K | 34.4K | +130% | $0 | |
| 2022-02-17 | 2022-02-15 | ANIP | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $40.25 | -1,184 | 14.9K | -7% | -$47.7K |
Purchase Sale Sale after option exercise All abbreviations